In previous studies we observed that normal human epidermis forms 12-oxo-eicosatetraenoic acid (12oxo-ETE) and hepoxilin B 3 (HxB 3 ) as major eicosanoids, both being elevated in psoriasis. We also observed that normal epidermis, in a reaction probably catalyzed by 12-lipoxygenase, only synthesize one of the two possible 10-hydroxy epimers of HxB 3 . We have now extended these previous studies investigating further transformation of HxB 3 into trioxilin B 3 (TrXB 3 ) and esteri®cation of both into phospholipids. Phospholipids were extracted from normal epidermis and from psoriatic scales. A combination of high performance liquid chromatography and gas chromatography±mass spectrometry analysis demonstrated the occurrence of HxB 3 and TrXB 3 in the phospholipids of psoriatic lesions. Alkaline-and phospholipase-A 2 -mediated hydrolysis of the phospholipids yielded similar quantities of both HxB 3 and TrXB 3 indicating their preference for the sn-2 position of glycerophospholipids. The thin layer chromatography analysis of the phospholipid classes after incubation of epidermal cells with [ 14 C]-labeled HxB 3 , TrXB 3 , 12-hydroxy-eicosatetraenoic acid (12-HETE), 12-oxo-ETE, or 15-HETE showed that 12-HETE was the most esteri®ed (12-HETE > 15-HETE > TrXB 3 > 12-oxo-ETE > HxB 3 ). HxB 3 and TrXB 3 were mainly esteri®ed in phosphatidyl-choline and phosphatidyl-ethanolamine. HxB 3 was also enzymatically converted into TrXB 3 in vitro. HxB 3 epoxide hydrolase-like activity was not observed when boiled tissue was incubated with [ 14 C]-HxB 3 , this activity being located in the cytosol fraction (100,000 Q g supernatant) of fresh tissue. These ®ndings suggest that in vivo some part of HxB 3 is transformed into TrXB 3 and both compounds are partially incorporated into the phospholipids. Key words: human epidermis/12-lipoxygenase/arachidonic acid. J Invest Dermatol 118: 139±146, 2002 1 2-Lipoxygenase (12-LO) is the major arachidonic acid (AA) oxygenation pathway in epidermal cells with total product formation generally exceeding cyclooxygenase activity (Holtzman et al, 1989; Sola Â et al, 1992) . Platelettype 12-LO has been found to be the predominant isoenzyme expressed in human and murine skin epidermis (Takahashi et al, 1993; Hussain et al, 1994; Krieg et al, 1995) and an``epidermal''-type 12-LO that functionally resembles the platelet-type 12-LO is also present in murine epidermis (Van Dijk et al, 1995; Funk et al, 1996; Kinzig et al, 1997) . We previously reported that, in addition to 12-hydroxyeicosatetraenoic acid (12-HETE), normal human epidermis incubated with exogenous AA produces 12-oxo-eicosatetraenoic acid (12-oxo-ETE), hepoxilin A 3 (HxA 3 ), and hepoxilin B 3 (HxB 3 ) through the 12-LO pathway Anto Ân and Vila, 2000) . Recently, we also observed increased levels of nonesteri®ed hepoxilins and trioxilins in the psoriatic scales (Anto Ân et al, 1998) . Normal human epidermis synthesized only one of the two possible 10-hydroxy epimers of HxB 3 whose formation is probably catalyzed by 12- LO (Anto Ân et al, 1995; Anto Ân and Vila, 2000) . Hepoxilins exert action on plasma permeability on skin (Laneuville et al, 1991; Wang et al, 1996 Wang et al, , 1999a 1999b) , and induce a speci®c-receptor-dependent Ca 2+ mobilization from endogenous sources (Dho et al, 1990; Laneuville et al, 1993) and the release of AA and diacylglycerol . Interestingly, only the epimer 10(R)-HxB 3 , which is probably the epimer synthesized by normal epidermis Anto Ân and Vila, 2000) , stereospeci®cally enhances the vascular permeability evoked by intradermal injection of the platelet-activating factor 1999a; 1999b) .
On the other hand, less polar eicosanoids and octadecanoids, such as monohydroxy and epoxy derivatives of arachidonic and linoleic acids, have been found to esterify into cell phospholipids. Oxidized phospholipids have pro-in¯ammatory activities and are involved in atherogenesis, psoriasis, and other in¯ammatory diseases. In human epidermis, HxB 3 can be further converted into trioxilin B 3 (TrXB 3 , 10,11,12-trihydroxy-5,8,14-eicosatrienoic acid) . As relevant biologic activity for 9, HxB 3 , hepoxilin B 3 , 8, 14eicosatrienoic acid;  LO, lipoxygenase; ME-H-TMS, hydrogenated methyl ester trimethylsilyl ether; ME-TMS, methyl ester trimethylsilyl ether; 12oxo-ETE, 12-oxo-eicosatetraenoic acid; PhC, phosphatidyl-choline; PhE, phosphatidyl-ethanolamine; PhI, phosphatidyl-inositol; PhS, phosphatidylserine; RP-HPLC, reverse phase-high performance liquid chromatography; SPh, sphingomyelin; TrXA 3 , trioxilin A 3 , 8, 11, 9, 14eicosatrienoic acid; TrXB 3 , trioxilin B 3 , 10, 11, 8, 14eicosatrienoic trioxilins has not been reported (Pace-Asciak et al, 1999) these compounds could represent a pathway for hepoxilin inactivation. Enzymatic transformation of hepoxilins into trihydroxy compound was originally reported in rat lung (Pace-Asciak et al, 1983) . No data about the enzymatic metabolism of HxB 3 in human epidermis are at present available, however. This prompted us to extend our previous investigations 1998; Anto Ân and Vila, 2000) on the presence of HxB 3 in the phospholipid fraction of psoriatic lesions, on HxB 3 incorporation into the different phospholipid classes in human epidermal cells, and on the enzymatic pathways involved in the catabolism of HxB 3 .
MATERIALS AND METHODS

Materials
[1± 14 C]-AA (55±58 mCi per mmol) was supplied by Amersham Ibe Ârica (Madrid, Spain). Phospholipase A 2 from bee venom was supplied by Sigma-Aldrich Quõ Âmica (Madrid, Spain). Hydrated platinum (IV) oxide was purchased from ICN Biochemicals (Costa Mesa, CA). Hydrogen gas was purchased from Abello Â Oxõ Âgeno-Linde (Barcelona, Spain). 1-Stearoyl-2-[1± 14 C]-arachidonoyl-L-3-phosphatidylcholine was obtained from Amersham Ibe Ârica. (T)-HxB 3 were from Cascade Biochem (Berkshire, U.K.). All high performance liquid chromatography (HPLC) solvents were supplied by Scharlau (Barcelona, Spain) and solvents for mass spectrometry analysis and N,O-bis-(trimethylsilyl)-tri¯uoroacetamide (BSTFA) were purchased from Merck (Darmstadt, Germany).
Source of normal human epidermis fragments and epidermal cell suspensions
Epidermis was isolated from normal skin, obtained from plastic surgery, using the Liu and Karasek technique (Liu and Karasek, 1978) with minor modi®cations (Sola Â et al, 1992) . Brie¯y, narrow strips of skin were cut and rinsed twice in phosphate-buffered saline, pH 7.4, free of Ca 2+ and Mg 2+ (PBS*). The strips were then placed in PBS* containing 0.5% trypsin (wt/vol) (Difco Laboratories, Paisley, Scotland) and kept at 37°C for 50±60 min. When dermo-epidermal detachment occurred, epidermal strips were transferred to a culture medium [Dulbecco's modi®ed Eagle's medium (DMEM) (Flow Laboratories, Irvine, Scotland) + 2 mM glutamine + 1 mM sodium pyruvate] containing 10% vol/vol fetal bovine serum (FBS) (Flow Laboratories). After peeling the epidermis from the dermis, the epidermal fragments were washed in DMEM. Epidermal fragments were isolated by ®ltration through a sterile gauze. The remaining sheets were divided into small fragments with a surgical blade (approximately 1 mm 2 ) and used for experiments without further manipulation. To obtain epidermal cell suspensions, after peeling the epidermis from the dermis, the epidermal fragments were then gently stirred for 10±15 min in DMEM supplemented with 2 mM glutamine, 1 mM sodium pyruvate, and 10% vol/vol FBS. The cellular suspension thus obtained was ®ltered through a sterile gauze to discard fragments of whole epidermis and then kept at 37°C until incubation. Only cell suspensions with viability greater than 95% were used. Fragments of fresh human epidermis and epidermal cell suspensions were used immediately.
Source of psoriatic scales
Scales from untreated patients with chronic stable plaque psoriasis involving more than 10% of body surface were removed by scraping with a surgical blade and stored at ±80°C under an N 2 atmosphere until analysis.
Isolation of phospholipid fraction from psoriatic scales Psoriatic scales (500±700 mg) were cut and mechanically homogenized with a Turrax T-8 in 3 ml of degassed distilled water containing 0.025½ (wt/ vol) BHT placed in an ice-water bath under an N 2 atmosphere. Next, 100,000 cpm of 1-stearoyl-2-([1± 14 C]-arachidonyl)-phosphatidylcholine were added as internal standard. Immediately, total lipids were extracted as described previously (Bligh and Dyer, 1959) . Extracts of CHCl 3 were dried under an N 2 stream and redissolved in 200 ml of CHCl 3 .
Phospholipids were separated from free fatty acids and neutral lipids as described previously (Kaluzny et al, 1985) using solid phase extraction chromatography. All solvents were supplemented with 0.025½ (wt/vol) BHT and the extraction was performed under an N 2 atmosphere.
Hydrolysis of ester bonds
The phospholipid fraction was divided in two aliquots and phospholipids were hydrolyzed by following two different procedures: alkaline saponi®cation and treatment with puri®ed phospholipase A 2 (PLA 2 ). For alkaline saponi®cation phospholipid extracts were dried under an N 2 stream, the residue was redissolved in 850 ml of MeOH/CHCl 3 8:1, and 150 ml 40% wt/vol KOH were added. The mixture was allowed to react for 30 min at 60°C under an N 2 atmosphere . The reaction was stopped by adding 700 ml of 50 mM phosphate buffer pH = 7.4 and acidifying until pH 2± 3. Free fatty acids were then extracted twice with 2 ml diethyl ether/ hexane 1:1. The reaction yield measuring release of [1± 14 C]-AA from 1stearoyl-2-[1± 14 C]-arachidonoyl-L-3-phosphatidylcholine was about 94%.
For speci®c hydrolysis of the sn-2 position, phospholipid extracts were dried under an N 2 stream, and the residue was redissolved in 10 ml of CHCl 3 and 70 ml of 30 mM borate buffer (pH = 9.0) supplemented with 1.6 mM CaCl 2 . The mixture was then shaken vigorously and CHCl 3 was removed under an N 2 stream. 850 U of bee venom PLA 2 in 85 ml of 30 mM borate buffer pH 9.0 were added and the mixture was allowed to react for 45 min at 37°C under an N 2 atmosphere with continuous agitation. Afterwards, another 850 U of PLA 2 were added and allowed to react for another 100 min (Smiley et al, 1991) . Reaction was stopped by acidi®cation until pH 2±3 and lipids were extracted as described by Bligh and Dyer (1959) . After analysis of the free [ 14 C]-AA released from 1-stearoyl-2-[1± 14 C]-arachidonoyl-L-3-phosphatidylcholine the yield of the reaction was about 96%.
Preparation of puri®ed [14C]-labeled HxB3, 12-oxo-ETE, and 12-HETE
Labeled 12-LO-derived eicosanoids were obtained from incubations of fragments of human epidermis, previously treated with 200 mM aspirin for 15 min, with 100 mM [ 14 C]-AA for 30 min at 37°C, and processed as described previously (Anto Ân and Vila, 2000) . Supernatants of several incubations were mixed and processed together. Supernatants of the incubations, which had a ratio MeOH:H 2 O of 1:1 and a pH of 2±3, were extracted three times with half a volume of diethyl ether:hexane 1:1. Extracts were evaporated under an N 2 stream until dryness, redissolved in the eluent of reverse phase high performance liquid chromatography (RP-HPLC), and chromatographied as described later. Fractions containing hepoxilins (14±20 min) and 12-oxo-ETE plus 12-HETE (25±33 min) were collected and puri®ed by straight-phase HPLC as reported previously . The speci®c activity of the labeled compounds was assumed to be the same as the [ 14 C]-AA batch used in their preparation as AA is labeled in the C of the carboxyl group, which is conserved in all these compounds.
Preparation of puri®ed [ 14 C]-labeled TrXB 3 Labeled TrXB 3 was obtained from incubations of fragments of human epidermis with 10 mM [ 14 C]-labeled HxB 3 for 30 min at 37°C. After the incubation period one volume of methanol and 1 M HCl to yield a pH of 2±3 were added. Supernatants of several incubations were mixed and processed together. These supernatants were then extracted three times with half a volume of diethyl ether:hexane 1:1. Extracts were evaporated under an N 2 stream until dryness, redissolved in the eluent of RP-HPLC, and chromatographied as described above. The fraction containing TrXB 3 (4±11 min) was collected and puri®ed by straight-phase HPLC as reported previously . The speci®c activity of the labeled TrXB 3 was assumed to be the same as that of [ 14 C]-HxB 3 .
Preparation of puri®ed [ 14 C]-labeled 15-HETE
[ 14 C]-15hydroperoxyeicosatetraenoic acid (15-HPETE) was obtained by incubating [ 14 C]-AA with soybean LO and was puri®ed by straightphase HPLC, after reduction with NaBH 4 , as previously described (Camacho et al, 1995) . The speci®c activity of the labeled 15-HETE was assumed to be the same as that of the [ 14 C]-AA batch used in its preparation.
Cell fractionation and incubation of cell fractions
Epidermis fragments (1±2 g) were homogenized and microsomal (100,000 Q g pellet) and cytosolic (100,000 Q g supernatant) fractions were obtained as described previously (Anto Ân and Vila, 2000) and incubated with 10 mM [ 14 C]-HxB 3 or unlabeled HxB 3 (as required) at 37°C for 30 min. Eicosanoids were analyzed by RP-HPLC, and by gas chromatography± mass spectrometry (GC-MS) when necessary, as described below.
Esteri®cation of eicosanoids into phospholipids
Ten million epidermal cells in suspension were incubated in 0.5 ml of RPMI-1640 containing 10 mM of [ 14 C]-15-HETE, [ 14 C]-12-HETE, [ 14 C]-12-oxo-ETE, [ 14 C]-HxB 3 , or [ 14 C]-TrXB 3 for 4 h at 37°C. Reactions were stopped by adding a volume of a cold solution of 2% acetic acid in methanol. Cells were then centrifuged and supernatants were stored at ± 80°C for further analysis. Pellets were suspended in 1.5 ml of 2% acetic acid in methanol followed by 1.5 ml of water. Lipids were extracted according to the method described by Bligh and Dyer (1959) . Extracts were dried under an N 2 stream and the residues were redissolved in 35 ml of methanol:chloroform 1:2. Labeled phospholipids were analyzed as previously described (Godessart et al, 1996) .
RP-HPLC analysis
Chromatography was performed as previously described (Anto Ân et al, 1998) . Quantitative analysis of 12-LO-derived compounds was done by injecting the samples directly into the column without further manipulation. The column was then coupled on line with a radioactivity detector (Beckman-171) equipped with a liquid scintillation cell. Eluents were mixed with scintillation cocktail pumped at 3 ml per min. Data from the detector were processed with a System Gold Software Beckman in a PC computer.
When isolation of eluted material was required, fractions were collected either on exit from the radioactivity detector equipped with a solid scintillation cell, or from the column, depending on labeled or unlabeled samples. In this way we collected fractions of TrXs at 4± 11 min, Hxs at 14±20 min, HODEs at 20±25 min, 12-oxo-ETE (and also HODEs and 15-HETE) at 25±27 min, and HETEs 27±40 min. These fractions were later concentrated by liquid±liquid extraction after adjusting the MeOH:H 2 O ratio to 1:1. Dried extracts were then derivatized for GC-MS analysis. Moreover, [1± 14 C]-AA from an internal standard was collected in order to assess quantitative ester hydrolysis and counted in a liquid scintillation counter. Both kinds of hydrolysis were quantitative.
Derivatization
All fractions except that of 12-oxo-ETE were derivatized to their hydrogenated methyl ester trimethylsilyl ethers (ME-H-TMS) as described previously (Anto Ân et al, 1998) . 12-oxo-ETE was ®rst transformed into its methyl ester trimethylsilyl ether (ME-TMS), to demonstrate it was not contaminated with 12-HETE, before transformation to its ME-H-TMS derivative. All samples were dried and redissolved in heptane/BSTFA.
GC-MS analysis
Analysis by GC-MS was performed as previously described (Anto Ân et al, , 1998 . In this case, the GC column was a TRB-1 fused silica capillary column (15 m length, 0.25 mm internal diameter, 0.25 mm ®lm thickness, Tracer Analõ Âtica, Barcelona, Spain). The gas chromatograph and mass spectrometer were Hewlett-Packard 6890 series and 5973 model, respectively.
RESULTS
HxB 3 and TrXs are present in the phospholipid fraction of psoriatic lesions
After isolation, the phospholipids were hydrolyzed by two procedures: treatment with puri®ed PLA 2 or with KOH. Samples were then subjected to HPLC fractionation. Hx and TrX fractions were then derivatized and subjected to GC-MS analysis using the full scan mode. Monitoring suitable ions for HxB 3 (m/z 73, 269, 282, and 311), the ME-TMS derivatives of the Hxs fraction from psoriatic scales subjected to GC-MS analysis eluted as a single peak. The EI mass spectrum was consistent with the structure of 10-hydroxy-11,12-epoxy-5,8,14-eicosatrienoic acid (HxB 3 ) and it was essentially identical to that obtained with authentic (T)HxB 3 . (See our previous studies for details of mass spectra (Anto Ân et al, , 1998 .) The fragments monitored in the hydrogenated samples were at m/z 73, 257, 273, and 287. Samples of phospholipids from psoriatic patients showed three peaks with CN of 22.65, 22.80, and 22.96, essentially with identical mass spectra consistent with the structure of hydrogenated HxB 3 . The ME-H-TMS derivative of authentic (T)HxB 3 yielded only two peaks, at CN 22.80 and 22.96 1998) . Based on these results, we concluded that not only the two 10-hydroxy epimers of HxB 3 were present in the phospholipids of psoriatic lesions but, as occurred with the free acid fraction (Anto Ân et al, 1998) , another isomer was also present. No HxB 3 was detected in the phospholipids of normal epidermis (n = 6) and heel callus from normal and psoriatic subjects (n = 3). As expected, HxA 3 was not detected in the phospholipid fraction of either psoriatic scales or normal epidermis as it was not stable under our work-up conditions.
The ME-TMS derivatives of TrXs were analyzed monitoring m/ z 213 (corresponding to the methyl terminal fragment from cleavage of the C11±C12 bond indicating the presence of a hydroxyl group at C12) and 243 (corresponding to the carboxyl terminal fragment from cleavage of the C8±C9 bond, which indicates the presence of a hydroxyl group at C8), for both trioxilin A 3 (TrXA 3 ) and 8,9,12-trihydroxyeicosatrienoic acid (8,9,12-THETrE), and at m/z 269 (corresponding to the carboxyl terminal fragment from cleavage of the C10±C11 bond indicating the presence of a hydroxyl group at C10) for TrXB 3 . Three peaks monitoring at m/z 213 showed essentially identical mass spectra consistent with the structure of TrXA 3 (see our previous papers for details : Anto Ân et al, , 1998 . As occurred with the free acid fraction of psoriatic scales (Anto Ân et al, 1998) , the detection of three GC peaks indicates the presence of at least three diastereoisomers of TrXA 3 in the phospholipid fraction of psoriatic scales. Monitoring at m/z 269, two GC peaks had similar mass spectra consistent with the TrXB 3 structure. This indicates that the TrXB 3 was present in psoriatic samples as at least two diastereoisomeric forms. Monitoring the 243 ion mass we observed two peaks consistent with the structure of 8,9,12-THETrE. The presence of TrXs was also con®rmed by GC-MS analysis of the hydrogenated fractions. We were unable to detect TrXs in the phospholipids of normal epidermis (n = 6) and in heel callus from normal and psoriatic subjects (n = 3). Based on HPLC and GC-MS analysis we can conclude that HxB 3 and TrXs were present in the phospholipids of psoriatic lesions. For quantitative analysis we selected the ME-H-TMS derivatives of HXs, TrXs, HETEs, and HODEs as the most suitable due to their structure-speci®c fragmentation and their high relative intensity in the positive ion EI mode GC-MS (Anto Ân et al, 1998). As authentic TrXs were not commercially available, TrXs were only semiquantitatively evaluated. Table I shows the quantitative data from the analysis of the phospholipid fraction of psoriatic scales. As expected, we found that 12-HETE, 15-HETE, 13-HODE, and 9-HODE were present in signi®cant amounts in the phospholipids of psoriatic lesions, 13-HODE being the most abundant. HxB 3 was also present. Apparently, the most abundant triol in the phospholipids of psoriatic scales was TrXA 3 followed by TrXB 3 , whereas 8,9,12-THETrE was present in small amounts. Results in Table I show that although the amount of all the eicosanoids and octadecanoids analyzed was slightly lower in the samples treated with PLA 2 , differences with respect to those in which phospholipids were hydrolyzed with KOH failed to reach signi®cance.
HxB 3 and TrXB 3 were mainly esteri®ed in phosphatidylcholine (PhC) and phosphatidyl-ethanolamine (PhE)
To observe the esteri®cation of the HxB 3 and TrXB 3 into the different classes of phospholipids in comparison with 12-HETE, 12-oxo-ETE, and 15-HETE, the radioactivity associated with each phospholipid class was evaluated after incubation of epidermal cell suspensions with 10 mM [ 14 C]-labeled substrates for 4 h. Results in Table II show that all eicosanoids tested were incorporated into cell phospholipids 12-HETE > 15-HETE > TrXB 3 > 12-oxo-ETE > HxB 3 . Each eicosanoid exhibited a characteristic pattern of esteri®cation, 12-HETE being the most esteri®ed (PhC > PhE > phosphatidyl-serine (PhS) » sphingomyelin (SPh) > phosphatidyl-inositol (PhI). PhC and PhE were the phospholipid classes in which the eicosanoids were in general mainly incorporated. In particular, esteri®cation of HxB 3 and TrXB 3 were only detectable in PhC > PhE. Results concerning HxB 3 in Table II are thus approximate, as a part of the radioactivity associated with the phospholipids was probably due to TrXB 3 . Whereas the amount of the 12-LO-derived compounds incorporated into PhI was relatively low, however, the relative amount of 15-HETE incorporated into PhI was remarkable. It was also notable that the amount of 12-oxo-ETE incorporated into PhS was the highest compared with the other compounds assayed (PhS > PhC > PhE » PhI » SPh).
HxB 3 was enzymatically transformed into TrXB 3 by epidermal cells
Substrate concentration kinetics were performed by incubating fragments of human epidermis with a range of [ 14 C]-AA for 30 min and then analyzing by HPLC. Figure 1 shows a typical RP-HPLC chromatogram from samples of human epidermis incubated with 100 mM [ 14 C]-AA. As expected, four peaks corresponding to 12-LO-derived eicosanoids were observed, the identities of which were con®rmed by GC-MS analysis: trioxilins (TrXB 3 , TrXA 3 , and 8,9,12-THETrE, which migrated unresolved), HxB 3 , 12-oxo-ETE, and 12-HETE. Results in Fig 2 showed that 12-LO activity was almost linear in the range of substrate concentrations assayed (5±100 mM) indicating that the range assayed was far from that which would yield the apparent maximum velocity. Results expressed as a ratio of each 12-LOderived eicosanoid to total 12-HPETE showed that 12-HETE decreased as substrate concentration increased, whereas 12-oxo-ETE and TrXs increased with substrate concentration. The relative amount of HxB 3 was similar in all AA concentrations tested, suggesting that the rate of further transformations of HxB 3 increased with the substrate concentration.
To observe further transformations of HxB 3 , suspensions of human epidermal cells (20 Q 10 6 cell per ml) were incubated with 10 mM of [ 14 C]-HxB 3 , at 37°C for 4 h. Compounds in the supernatant were analyzed. As Fig 3 shows , part of the HxB 3 was found transformed into TrXB 3 (47.3% T 11.7%, mean T SD, n = 4). The identity of the TrXB 3 HPLC peak (Fig 4) was con®rmed by GC-MS analysis of parallel incubations with nonlabeled material. We performed a full scan GC-MS of ME-TMS derivatives of the collected peak corresponding to TrXB 3 . Speci®c ion monitoring at m/z 269 was performed and two peaks were observed (Fig 4) . The two GC peaks had essentially identical mass spectra consistent with the TrXB 3 structure 1998) , which was present in at least two stereoisomeric forms. For additional support for the presence of two isomers of TrXB 3 in the incubates, the HPLC fraction was subjected to catalytical hydrogenation and was analyzed by full scan GC-MS, monitoring the speci®c ion m/z 273. Two GC peaks (Fig 4) with a fragmentation The internal standard was added, lipids were extracted, and phospholipids puri®ed and hydrolized by alkaline saponi®cation or by means of PLA 2 . Free acids were extracted, separated by HPLC, and derivatized to their ME-H-TMS derivatives prior to GC-MS analysis. Quanti®cation was performed taking into account the curves built with authentic standards. As standards were not available for TrXs, semiquantitative evaluation was accomplished by calculating the ratio of the area of the corresponding GC peak to that of 12-HETE.
c Mean T SD, n = 6. 0.5 ml of epidermal cell suspensions (20 Q 10 6 cells per ml) were incubated with 10 mM of [ 14 C]-labeled eicosanoids for 4 h and the radioactivity associated with the indicated phospholipid classes was evaluated as previously described (Godessart et al, 1996) . consistent with a 10,11,12-trihydroxy-arachidic acid structure were observed (Anto Ân et al, , 1998 .
The``HxB 3 epoxide hydrolase'' activity was located in the cytosolic fraction To locate the``HxB 3 epoxide hydrolase'' activity, the supernatant and pellet, obtained after centrifugation of homogenate epidermis at 100,000 Q g, were incubated with 10 mM [ 14 C]-HxB 3 and labeled eicosanoids were analyzed. The enzymatic origin of TrXB 3 was supported by the fact that boiled tissue did not produce TrXB 3 when incubated with [ 14 C]-HxB 3 (Fig 5) . The 100,000 Q g pellet did not transform HxB 3 into TrXB 3 ; in contrast, the supernatant ef®ciently converted HxB 3 into TrXB 3 (90.3 T 36.0 pmol per 30 min per 100 mg protein, mean T SD, n = 3).
DISCUSSION
Chromatographic behavior of HxB 3 shows that it is a hydrophobic compound but less so than monohydroxy acids. We expected that, as occurred with other hydrophobic eicosanoids and octadecanoids, HxB 3 could remain associated to the lipid fractions and would be retained in the in¯ammatory lesions. This concept is consistent with the fact that nonesteri®ed HxB 3 is notably elevated in psoriatic lesions (Anto Ân et al, 1998) . Nonpolar eicosanoids are not only present in the in¯ammatory lesions as a free form but also tend to esterify in cell phospholipids, which results in large amounts of monohydroxy fatty acids esteri®ed into cell phospholipids in in¯ammatory lesions (Baer et al, 1991; Ku Èhn et al, 1992) . Indeed, among the eicosanoids and octadecanoids only the hydroxy and epoxy derivatives have been reported to be incorporated into cellular phospholipids (Stenson and Parker, 1979; Schade et al, 1987; Brezinski and Serhan, 1990; Wang et al, 1990; Brinkman et al, 1991; Bernstrom et al, 1992) . Here we report that HxB 3 is also present in psoriatic lesions esteri®ed in the phospholipids in an HxB 3 :12-HETE ratio of 0.19 after both alkaline saponi®cation and PLA 2 -catalyzed hydrolysis. This ratio is similar to that found on analyzing free acids (0.15, from Anto Ân et al, 1998) . The fact that there were no signi®cant differences between alkaline-and PLA 2catalyzed hydrolysis regarding HxB 3 indicated that in psoriatic lesions HxB 3 is mainly esteri®ed in the sn-2 position of glycerophospholipids. Esteri®ed HxB 3 and TrXB 3 were not detected either in normal epidermis or heel callus from normal and psoriatic subjects, indicating that they were not formed in signi®cant amounts in places other than psoriatic lesions. Taking into account that these compounds were also undetectable in the Chromatography was performed as described in Fig 1. Part of the HxB 3 was found transformed into TrXB 3 (47.3% T 11.7%, mean T SD, n = 4). The identity of the TrXB 3 peak was con®rmed by GC-MS analysis of parallel incubations with nonlabeled material. free form in normal epidermis (Anto Ân et al, 1998) , the presence of HxB 3 and TrXB 3 seems to be a characteristic feature of the psoriatic lesion.
Metabolism of AA in human epidermis through the 12-LO pathway results in the formation of HxB 3 , 12-oxo-ETE, and several triols in addition to 12-HETE (Anto Ân et al, 1995) . In particular, high amounts of HxB 3 and 12-oxo-ETE are produced by whole human epidermis. Unlike hemin-catalyzed formation of HxB 3 , normal human epidermis only produced one of the two possible 10-hydroxy epimers Anto Ân and Vila, 2000) . Samples from authentic hydrogenated racemic HxB 3 yielded two GC peaks, which correspond to the two epimeric forms at C10 Anto Ân and Vila, 2000) . As occurred regarding free acids (Anto Ân et al, 1998) , in addition to these two peaks phospholipids of psoriatic samples yielded a major additional peak with an MS spectrum also consistent with the structure of the hydrogenated HxB 3 . As previously discussed (Anto Ân et al, 1998) , it is possible that other isomers of HxB 3 corresponding to 10hydroxy-cis-epoxides may be formed by rearrangement of an AAperoxide radical intermediate as a result of an autocatalytic process induced by free radicals.
Cellular phospholipids containing oxidized forms of AA or linoleic acid could be originated in two ways: (i) direct oxidation of the fatty acid substituents at the sn-1 or sn-2 positions of glycerophospholipids and diacylglycerol and (ii) re-esteri®cation of oxidized acids with lysoglycero-phospholipids. Enzymatic oxidation of polyunsaturated lipids within glycerophosphatide substrates has been demonstrated under certain conditions, particularly in cell-free systems using exogenously supplied 15-LO (Brash et al, 1987; Ku Èhn et al, 1990) . Consistently, all compounds tested were esteri®ed in vitro into phospholipids when epidermal cells were incubated with labeled compounds. Our in vitro data and data elsewhere (Brezinski and Serhan, 1990; Karara et al, 1991; Legrand et al, 1991) , argue in favor of remodeling as a signi®cative origin of oxidized phospholipids in psoriatic lesions. We report herein the generation of a new class of oxidized phospholipids by esteri®cation of oxo, epoxy-hydroxy, and trihydroxy eicosanoids in cell phospholipids, but to a lesser extent than hydroxy compounds. Nevertheless, whereas HxB 3 was found in the phospholipid Human epidermal cell suspensions (20 Q 10 6 cell per ml) were incubated with 10 mM [ 14 C]-HxB 3 for 4 h at 37°C. One volume of cool methanol was added to the supernatants and samples were subjected to RP-HPLC as described in Fig 1. RP-HPLC peak corresponding to TrXB 3 was collected and derivatized. Full scan GC-MS of ME-TMS derivatives of native and hydrogenated TrXB 3 fraction were performed as described in Methods. Figure 5 . Formation of TrXB 3 from HxB 3 was enzymatic and the HxB 3 epoxide hydrolase-like activity was located in the cytosolic fraction. Representative chromatograms of boiled epidermis and cytosolic and microsomal fractions incubated with [ 14 C]-HxB 3 are shown. Human epidermis was mechanically homogenized and centrifuged at 100,000 Q g for 90 min at 4°C. Protein equivalent amounts (250 mg) of boiled homogenate and 100,000 Q g supernatant and pellet were incubated with 10 mM [ 14 C]-HxB 3 at 37°C for 30 min. Reactions were stopped with one volume of cool methanol and samples were analyzed by RP-HPLC. Chromatography was performed as described in Fig 1. 100,000 Q g supernatant ef®ciently converted HxB 3 into TrXB 3 (90.3 T 36.0 pmol per 30 min per 100 mg protein, mean T SD, n = 3). fraction of psoriatic scales, 12-oxo-ETE was not detected in the samples from psoriatic patients although it was esteri®ed when incubated in vitro with epidermal cells. Indeed, neither was 12-oxo-ETE found in the free form in psoriatic lesions (unpublished results) . This may be due to a further transformation of 12-oxo-ETE in vivo; our results are not conclusive with respect to this point.
Like 12-HETE, HxB 3 and TrXB 3 were mainly esteri®ed in PhC and PhE. 12-oxo-ETE was esteri®ed into PhI, although, consistently with data reported by others (Brezinski and Serhan, 1990; Legrand et al, 1991; Girton et al, 1994) , 15-HETE exhibited the highest preference for PhI when compared with the other compounds tested. The generation of oxidized phospholipids may be of relevance, as these phospholipids interfere with PhC and PhI signaling pathways by the generation of altered phosphatidic acids and diacylglycerols (Brezinski and Serhan, 1990; Legrand et al, 1991 Legrand et al, , 1996 Cho and Ziboh, 1994a, b; Wallukat et al, 1994) . Accumulation of HxB 3 in the sn-2 position of glycerophospholipids could also serve as a storage pool for agonist-mediated release of HxB 3 from PhC and PhE.
Further conversion of HxB 3 in human epidermis into TrXB 3 could represent a pathway for hepoxilin inactivation. HxB 3 , which was stable under our work-up conditions, was only enzymatically transformed to TrXB 3 , as the conversion of HxB 3 into TrXB 3 was abolished by tissue boiling. As normal epidermis exclusively produces the 10(R)-hydroxy isomer of HxB 3 , the fact that we detected two stereoisomers of TrXB 3 suggests that they came from the opening of the epoxide ring in C11±C12, rather than from the two epimeric positions of the hydroxyl group at C10 in HxB 3 .
The``HxB 3 epoxide hydrolase'' activity was located almost exclusively in the cytosol of the epidermal cells, as we only detected TrXB 3 in the 100,000 Q g supernatant fraction when incubated with puri®ed [ 14 C]-HxB 3 . The cytosolic location of``HxB 3 epoxide hydrolase'' in human epidermis is consistent with that reported by Pace-Asciak and Lee (1989) who found``hepoxilin epoxide hydrolase'' activity in the 100,000 Q g supernatant of rat liver homogenates, although the authors did not provide data about the activity in the microsomal fraction. Nevertheless, the same authors found hepoxilin epoxide hydrolase-like activity located in the membrane fraction in platelets (Pace-Asciak et al, 1986) . This suggests that several hepoxilin epoxide hydrolase isoenzymes could be expressed in different tissues.
TrXA 3 was also present in the sn-2 position of glycerophospholipids, strongly suggesting that HxA 3 and/or TrXA 3 were also esteri®ed in the phospholipids. Nevertheless, we could not evaluate the quantity of HxA 3 present in the phospholipid fraction as HxA 3 was not stable under our work-up conditions. Support for the potential role of hepoxilins in the pathogenesis of in¯ammatory skin diseases includes their potent action on plasma permeability when injected subcutaneously (Laneuville et al, 1991; Wang et al, 1996 Wang et al, , 1999a and the detection of a considerable amount in psoriatic lesions in free form (Anto Ân et al, 1998) and also esteri®ed. Hepoxilins could play an autocrine role as intracellular messengers and a paracrine role modulating leukocyte activation (reviewed in Pace-Asciak et al, 1999) . The biologic role of these compounds on dermatoses is at present under research in our laboratory.
